Welcome to the VHGS II Resource Hub, a dedicated space created to provide participants with access to all materials shared during the Virtual Human Global Summit II, held in Barcelona and New York on October 23–24, 2025.
Presentations
This section includes the slide decks presented during the plenary sessions, roundtables and thematic tracks. Materials are listed in the order in which they appear in the program to make navigation easier.
Session A – The Evolving Vision for Virtual Human Efforts
- Paul Mc Greavy – Patients First! What do patients expect of medical virtual twins?
- Eric Stahlberg – A Changing Time: Updates since the First VHGS
- Marco Viceconti – From the Virtual Physiological Human to the Virtual Human Twin
- Liesbet Geris – Mapping the road towards the Virtual Human Twin
- Kyriacos Hatzaras – The European Commission Vision for the Virtual Human Twins Ecosystem
- Soroush Safaei – Virtual Twins as Tools for Personalized Clinical Care (VITAL European Project)
- Oscar Camara – Virtual Humans: from Academy to Clinical Translation
- Michael Forstner – Developments towards truly personalized medicine
- Jerome Noailly – Your Digital Twin: Predicting and Preventing Joint Pain
- Belinda Seto – Multimodal Artificial Intelligence Models on Human Health
Session B – Applications of Virtual Human Models and Digital Twins
- Florence D. Hudson – TIPPSS to Protect Virtual Humans from Real Risks
- Bissan Al-Lazikani – Digital twins across scales: Informing cancer drug discovery and development
- Jazmin Aguado Sierra – In Silico clinical trials as a reality: the case of the cardiovascular system
- Cezary Mazurek – Toward a Transdisciplinary Understanding of Neurodegenerative Mechanisms: From Quantum Scales to Virtual Humans
- Arnau Montagud – Advances Towards the Virtual Human Twin at BSC
- Alfonso Bueno-Orovio – Digital Twins for Cardiovascular Disease
- Maria Klapa – Therapeutic application V: Metabolic & Protein Networks
- Adrian Ponce Álvarez – Therapeutic Application II: Whole-brain models, brain states, and phase transitions
- Eva Giralt – Therapeutic Application II: The Brain – TARGET Project – Health Virtual Twins for the Personalised Management of Stroke Related to Atrial Fibrillation (Target-Horizon.eu)
- Morteza Rasouligandomani – Therapeutic Application III: Patient-Specific Biomechanical Digital Twin For Superior Spine Care Twin for Superior Spine Care from Prevention to Surgical Planning
- Sebastian Polak – Virtual Humans – Various Approaches, Common Aim. What QSP and PBPK Bring to the Table?
- Pras Pathmanathan – The regulatory virtual human – The FDA vision
- Andrea Manfrin – MHRA Approach to Innovation in Clinical Trials
Session C – The Evolving Vision for Virtual Human Efforts
- Peter Hunter – The Use of Bond Graphs in Multiscale Physiological Modelling
- Heiko Enderling – Digital twins in Radiation Oncology
- Jun Deng – Developing a Digital Twin Framework for Personalized Radiotherapy of NSCLC
- Jerry Lee – Building Patient Journey Lines: Lessons Learned and Opportunities for Molecular Driven Adaptive Learning
- Meifeng Lin – The Virtual Human Twin, According to Brookhaven National Lab
- Olivier Elemento – Building Cancer Digital Twins for Precision Oncology
Session D – Infrastructure and Environments for Digital Twins in Biomedicine
- Prasad Babarenda Gamage – New Zealand 12 Labourers Project: Enabling development and clinical translation of virtual human twins
- Natalia Jimenez/Manu Pillai – HPC on AWS: Shaping the Future of Virtual Humans Together
- Sabato Mellone/Amaryllis Raouzaiou – EDITH’s experience on the Virtual Human software Infrastructure
- Beatriz Eguzkitza – An HPC Virtual Human example: the respiratory system
- Marc Paradis – Where AI and Virtual Humans Meet: Next Generation Data Assets
- Ravi Mahajan – The Virtual Human Twins’ Potential in India
- Gokhan Ertaylan – From Prototype to Practice: Evaluating and Scaling Healthcare Digital Twins
- Jan Nygard – The Virtual Human Twins’ Potential in Scandinavia (Norway)
- Anil Srivastava – India: Virtual Human Initiatives
- Diego Arguello – Virtual Human Twins in Rare Disease: Perspectives and Vision of a Pharmaceutical Clinical Development Scientist
Session E – Community and Industry Adoption and Path Forward
- Anuj Kapadia – Building smarter simulations: insights from a Virtual Imaging Trial with 10,000 CT Scans
- Dan Isaacs – From Traditional to Intelligent to Generative: the Evolution of Digital Twins
- Andrea Townsend-Nicholson – Virtual Humans in Medical Education and Training
- Michael Hill – Virtual Human Twins in MedTech: Now and in the Future
- Marco Ruscone / Adam Smelco – The Omics Virtual Human
- Georg Rast – How Drug Safety Strategies are Crafted
- Tina Morrison – Perspectives on Digital Twins and Verifiable Data + AI Pipelines
- Michele Barbier – Ethical Considerations in the Design of Virtual Human Twins
- Steven Bourke – The Power of Human Lived Experience in a Virtual Human World
- James Sharpe – Biology Systems Virtual Human II
Video Recordings
Here you will find the links to the session recordings from both Barcelona and New York.
These videos allow you to revisit key discussions, case studies and expert contributions that shaped this year’s edition of the VHGS.
Session A – The Evolving Vision for Virtual Human Efforts
Session B – Applications of Virtual Human Models and Digital Twins
Session C – The Evolving Vision for Virtual Human Efforts
Session D – Infrastructure and Environments for Digital Twins in Biomedicine
Session E – Community and Industry Adoption and Path Forward
Photo Gallery
A curated selection of photographs capturing the key moments of VHGS II—sessions, networking, speakers, panels and the overall atmosphere.
Click here to see all gallery!
VHGS Voices – Expert Interview Series
As part of the post-event content, we are pleased to share the VHGS Voices series—a collection of short interviews recorded during the Virtual Human Global Summit II in Barcelona.
About VHGS II
The Virtual Human Global Summit II brought together more than one hundred international leaders from computational science, regulatory agencies, medicine, biotech, industry, and patient communities to advance the development and adoption of virtual human twins in biomedical research and clinical environments.
This resource page reflects ELEM Biotech’s and the Steering Committee’s commitment to making summit materials available and supporting continued collaboration beyond the event.
Contact
For any questions regarding the content or to request additional material, please contact:
VHGS Organizing Committee
Email: vhgs25@virtualhumansummit.org